Related Experiment Video
Updated: Feb 27, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Left Atrioventricular Coupling Index Predicts Poor Prognosis in Acute Myocardial Infarction: A Single-Center Cohort
Chuyun Chen1, Haolei Huang1, Jia Jia1,2
1Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
Insights
The novel left atrioventricular coupling index (LACI) predicts poor outcomes in acute myocardial infarction (AMI) patients. Higher LACI levels are linked to increased risks of major adverse cardiovascular events (MACE), aiding in secondary prevention strategies.
Area of Science:
- Cardiology
- Echocardiography
- Clinical Research
Background:
- The left atrioventricular coupling index (LACI) is a new parameter for assessing cardiac function.
- Its association with major adverse cardiovascular events (MACE) in acute myocardial infarction (AMI) patients requires further investigation.
Purpose of the Study:
- To evaluate the association between LACI and MACE in patients with AMI.
- To determine LACI's utility in risk stratification for secondary prevention.
Main Methods:
- Retrospective cohort study of 843 AMI patients.
- Transthoracic echocardiography performed on admission for LACI measurement.
- Median follow-up of 4.31 years with MACE as the primary endpoint.
Main Results:
- Median LACI was 0.24; 17.91% of patients experienced MACE.
- Optimal LACI cutoff for risk stratification identified as 0.257.
- Increased LACI associated with higher risks of MACE, all-cause death, cardiovascular death, and stroke after multivariable adjustment.
Conclusions:
- LACI is an independent predictor of poor prognosis in AMI patients.
- LACI can be a valuable tool for risk stratification in secondary prevention strategies.
Abstract:
(1) Background: The left atrioventricular coupling index (LACI) is a novel parameter for evaluating cardiac function. This study focused on its association with major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI) patients. (2) Methods: A retrospective cohort of AMI patients from Peking University First Hospital was enrolled. All underwent transthoracic echocardiography on admission for LACI measurement. The primary endpoint was MACE (a composite of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death). (3) Results: Among 843 AMI patients (62.07 ± 12.24 years, 77.94% male), the median LACI was 0.24 (IQR 0.18-0.33). During a median follow-up of 4.31 years, 151 patients (17.91%) developed MACE. The optimal LACI cutoff for risk stratification was 0.257. After multivariable adjustment, each standard deviation increase in LACI was associated with significantly elevated risks of MACE (HR 1.17, 95% CI 1.02-1.34), all-cause death (HR 1.19, 95% CI 1.05-1.35), cardiovascular death (HR 1.33, 95% CI 1.10-1.61), and stroke (HR 1.23, 95% CI 1.05-1.43). (4) Conclusions: LACI is an independent predictor of poor prognosis in AMI patients and may serve as a valuable tool for risk stratification in secondary prevention.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology

